An Investment Firm with Unrivaled Expertise in Regulated Industries
Washington, D.C-based private equity firm with over $14 billion of committed capital and extensive experience investing in industries that serve or are regulated by the government.
TEAM Technologies, an Arlington Capital Partners Portfolio Company, Acquires TAG3 Engineering to Expand Medical Device Design and Development Capabilities
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd.